Table 2 Symptom score and CA125 levels according to pathologic diagnosis
Benign (n= 209) | Borderline tumour (n= 17) | Ovarian cancer (n=112) | Metastatic (n= 3) | ||
|---|---|---|---|---|---|
Symptom score≥9 | Yes | 15 (7.2%) | 8 (47.1%) | 95 (84.8%) | 3 (100%) |
No | 194 (92.8%) | 9 (52.9%) | 17 (15.2%) | 0 (0%) | |
Ca125≥35U/mL | Yes | 53 (25.4%) | 14 (82.4%) | 97 (86.6%) | 3 (100%) |
No | 156 (74.6%) | 3 (17.6%) | 15 (13.4%) | 0 (0%) | |
Symptom score≥9 or Ca125≥35U/mL | Yes | 60 (28.7%) | 15 (88.2%) | 108 (96.4%) | 3 (100%) |
No | 149 (71.3%) | 2 (11.8%) | 4 (3.6%) | 0 (0%) | |